The first field trials of the chemically synthesized malaria vaccine SPf66: safety, immunogenicity and protectivity

Vaccine

Volumn 10, Issue 3, 1992, Pages 179-184

  Amador, Roberto ^a   Moreno, Alberto ^a   Valero, Victoria ^a   Murillo, Luis ^a   Mora, Ana Lucía ^a   Rojas, Mauricio ^a   Rocha, Claudia ^a   Salcedo, Margarita ^a   Guzman, Fanny ^a   Espejo, Fabiola ^a   Nũnez, Francisco ^b   Patarroyo, Manuel E ^a  

^a UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

^b Fuerzas Militares Tumaco Colombia ^*  (Colombia)

Author keywords

field trial; immunogenicity; Plasmodium falciparum; Plasmodium vivax; protectivity; safety; vaccine

Indexed keywords

MALARIA VACCINE; SYNTHETIC PEPTIDE;

ADULT; ANTIBODY RESPONSE; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; ERYTHEMA; HUMAN; INJECTION PAIN; MAJOR CLINICAL STUDY; MALE; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PROVOCATION TEST; SUBCUTANEOUS DRUG ADMINISTRATION;

AMINO ACID SEQUENCE; ANIMAL; DOUBLE-BLIND METHOD; FOLLOW-UP STUDIES; HUMAN; MALARIA, FALCIPARUM; MALE; MOLECULAR SEQUENCE DATA; PLASMODIUM FALCIPARUM; PROSPECTIVE STUDIES; PROTOZOAN VACCINES; SUPPORT, NON-U.S. GOV'T; VACCINES, SYNTHETIC;

EID: 0026567799     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0264-410X(92)90009-9     Document Type: Article

References (33)

1. Malaria: Resurgence, resistance and research
2. Malaria: The search for vaccine antigens and new chemotherapeutic strategies
3. Malaria: Resurgence, resistance and research
4. Immunization of monkeys against malaria by means of killed parasites with adjuvants
5. Immunization of man against falciparum and vivax malaria by use of attenuated sporozoites
6. Malaria: Immunity, vaccination and immunodiagnosis
7. Development of sporozoite vaccines
8. Genetic control of the immune response in mice to a Plasmodium falciparum sporozoite vaccine
9. Processing of the precursor to the major merozoite surface antigens of Plasmodium falciparum
10. A liver-stage-specific antigen of Plasmodium falciparum characterized by gene cloning
11. A 46000 dalton Plasmodium falciparum merozoite surface glycoprotein not related to the 185000–195000 dalton schizont precursor molecule: Isolation and characterization
12. Two apparently nonrepeated epitopes on gametes of Plasmodium falciparum are targets of transmission-blocking antibodies
13. Plasmodium falciparum antigens as target molecules for a protective immunization against malaria: an up to date review
14. Immunization with synthetic peptides of a Plasmodium falciparum surface antigen induces antimerozoite antibodies
15. Immunization of Aotus monkeys with recombinant proteins of an erythrocyte surface antigen of Plasmodium falciparum
16. Antibodies in malaria sera to parasite antigens in the membrane of erythrocytes infected with early asexual stages of Plasmodium falciparum
17. Antigens induced on erythrocytes by Plasmodium falciparum: Expression of diverse and conserved determinants
18. Protective synthetic peptides against experimental Plasmodium falciparum induced malaria
19. Induction of protective immunity against experimental infection with malaria using synthetic peptides
20. Safety and efficacy of a recombinant DNA Plasmodium falciparum sporozoite vaccine
21. Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoite
22. A synthetic vaccine protects humans against challenge with asexual blood stage of Plasmodium falciparum
23. Development of an asexual blood stage Malaria vaccine
24. Solid phase peptide synthesis
25. General method for the rapid solid-phase synthesis of large numbers of peptides: Specificity of antigen-antibody interaction at the level of individual amino-acid
26. Quantitation of Aspartate and Glutamate in HPLC analysis of phenylthiocarbamyl amino acids
27. Direct microsequence analysis of polypeptides using an improved sequenator, nonprotein carrier (Polybrene) and high pressure liquid chromatography
28. Studies on the humoral immune response to a synthetic vaccine against Plasmodium falciparum malaria
29. Use of synthetic and recombinant peptides in the study of host-parasite interactions in the malarias
30. Genetic control of the immune response
31. Principles of malaria vaccine trials
32. Primary structure of the merozoite surface antigen 1 of Plasmodium vivax reveals sequences conserved between different Plasmodium species